key: cord-0751291-wohkn4bx
authors: Atak, Mehmet Fatih; Farabi, Banu; Kalelioglu, Mehmet Berati; Rao, Babar K.
title: Pigmented purpuric dermatosis after BNT162B2 mRNA COVID‐19 vaccine administration
date: 2021-11-17
journal: J Cosmet Dermatol
DOI: 10.1111/jocd.14607
sha: 8ee9789f7ed1650e653dd2ec7e60acb34cd2559f
doc_id: 751291
cord_uid: wohkn4bx

nan

vaccine. 8 Herein, we report the second case of PPD developed 18 days after BNT162B2 vaccine in a young male patient without past medical history of any skin condition. 

This material is the authors' own original work, which has not been previously published elsewhere. The paper is not currently being considered for publication elsewhere. The paper reflects the authors' own research and analysis in a truthful and complete manner. The paper properly credits the meaningful contributions of co-authors and coresearchers. The results are appropriately placed in the context of prior and existing research. All sources used are properly disclosed (correct citation). Literally copying of text must be indicated as such by using quotation marks and giving proper reference. All authors have been personally and actively involved in substantial work leading to the paper, and will take public responsibility for its content.

The authors confirm that the data supporting the findings of this study are available within the article. 

Severe acute respiratory syndrome coronavirus 2 vaccines and cutaneous adverse reactions: a review

Pityriasis rosea following SARS-CoV-2 vaccination: a case series

Cutaneous smallvessel vasculitis following COVID-19 vaccine

Post-Covid cutaneous small-vessel vasculitis with features of Koebnerization

Systemic lupus erythematosus after COVID-19 vaccination: a case report

Guttate flare in a patient with chronic plaque psoriasis following COVID-19 infection: a case report

Cutaneous adverse reactions to COVID-19 vaccines: Insights from an immuno-dermatological perspective. Vaccines (Basel)

Widespread purpura annularis telangiectodes following mRNA SARS-CoV-2 vaccine

Immunohistologic studies in Schamberg's disease. Evidence for cellular immune reaction in lesional skin

Cell infiltrate in progressive pigmented purpura (Schamberg's disease): immunophenotype, adhesion receptors, and intercellular relationships

mRNA COVID-19 vaccine administration